The influence of 5-HT(2A) activity on a 5-HT(2C) specific in vivo assay used for early identification of multiple acting SERT and 5-HT(2C) receptor ligands.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Bioorganic & Medicinal Chemistry Letters

• Publication date

  2016-02-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bmcl.2015.12.071PMID 26748694
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

  2015cited by this paper
• Global, regional, and national incidence, prevalence, and YLDs for 301 acute and chronic diseases and injuries for 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013

  2015cited by this paper
• Controversies on the role of 5-HT(2C) receptors in the mechanisms of action of antidepressant drugs.

  2014cited by this paper
• Polypharmacology: challenges and opportunities in drug discovery.

  2014cited by this paper
• Design of novel multiple-acting ligands towards SERT and 5-HT2C receptors.

  2014cited by this paper
• Something's got to give: psychiatric disease on the rise and novel drug development on the decline.

  2013cited by this paper
• On the origins of drug polypharmacology

  2013cited by this paper
• Polypharmacology - foe or friend?

  2013cited by this paper
• Shifting from the single to the multitarget paradigm in drug discovery.

  2013cited by this paper
• Animal models of depression: molecular perspectives.

  2011cited by this paper
• Dual- and triple-acting agents for treating core and co-morbid symptoms of major depression: novel concepts, new drugs

  2011cited by this paper
• 5-HT2A and 5-HT2C receptors exert opposing effects on locomotor activity in mice

  2009cited by this paper
• Network pharmacology

  2007cited by this paper
• The effects of the 5-HT2C receptor antagonist SB242084 on locomotor activity induced by selective, or mixed, indirect serotonergic and dopaminergic agonists

  2006cited by this paper
• Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application.

  2006cited by this paper
• Designed multiple ligands. An emerging drug discovery paradigm.

  2005cited by this paper
• The efficiency of multi-target drugs: the network approach might help drug design.

  2004cited by this paper
• Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia

  2004cited by this paper
• From magic bullets to designed multiple ligands.

  2004cited by this paper
• LABORASTM : Initial pharmacological v alidation of a system allowing continuous monitoring of laboratory rodent beha v iour

  2003cited by this paper
• m-CPP hypolocomotion is selectively antagonized by compounds with high affinity for 5-HT2C receptors but not 5-HT2A or 5-HT2B receptors

  2001cited by this paper
• Comparisons of hallucinogenic phenylisopropylamine binding affinities at cloned human 5-HT2A, 5-HT2B and 5-HT2C receptors

  1999cited by this paper
• 6-Chloro-5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]-5-pyridyl]carbamoyl]- indoline (SB-242084): the first selective and brain penetrant 5-HT2C receptor antagonist.

  1997cited by this paper
• Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice

  1997cited by this paper
• Evidence that mCPP may have behavioural effects mediated by central 5‐HT1C receptors

  1988cited by this paper

• Convenient Diaryl Ureas as Promising Anti-pseudo-allergic Agents.

  2022cites this paper
• How can preclinical cognitive research further neuropsychiatric drug discovery? Chances and challenges

  2020cites this paper